dnaJ Peptide for Relieving Rheumatoid Arthritis - Contacts and Locations

dnaJ Peptide for Relieving Rheumatoid Arthritis

This study has been completed.

Study NCT00000435. Last updated on July 30, 2007. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000435

Locations


United States, Arizona
	University of Arizona Health Sciences Center
	Tucson, Arizona, United States, 85724-5093

United States, California
	Stanford University
	Palo Alto, California, United States, 94305
	University of California, Irvine Medical Center
	Orange, California, United States, 92868

United States, Colorado
	Denver Arthritis Center
	Denver, Colorado, United States, 80230

United States, Maryland
	Johns Hopkins University
	Baltimore, Maryland, United States, 21224

United States, Minnesota
	Mayo Clinic
	Rochester, Minnesota, United States, 55905

United States, Pennsylvania
	Guthrie Clinic
	Sayre, Pennsylvania, United States, 18840

United States, Washington
	Virginia Mason Research Center
	Seattle, Washington, United States, 98104

Sponsors and Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Investigators


Principal Investigator:	Salvatore Albani, MD	University of California, San Diego